మా గ్రూప్ ప్రతి సంవత్సరం USA, యూరప్ & ఆసియా అంతటా 3000+ గ్లోబల్ కాన్ఫరెన్స్ ఈవెంట్లను నిర్వహిస్తుంది మరియు 1000 కంటే ఎక్కువ సైంటిఫిక్ సొసైటీల మద్దతుతో 700+ ఓపెన్ యాక్సెస్ జర్నల్లను ప్రచురిస్తుంది , ఇందులో 50000 మంది ప్రముఖ వ్యక్తులు, ప్రఖ్యాత శాస్త్రవేత్తలు ఎడిటోరియల్ బోర్డ్ సభ్యులుగా ఉన్నారు.
ఎక్కువ మంది పాఠకులు మరియు అనులేఖనాలను పొందే ఓపెన్ యాక్సెస్ జర్నల్స్
700 జర్నల్స్ మరియు 15,000,000 రీడర్లు ప్రతి జర్నల్ 25,000+ రీడర్లను పొందుతున్నారు
Farnaz Samadi and Hamid Amini
Background: Inflammation is a prominent risk factor for Alzheimer’s disease. Then, lifestyle interventions such as exercise training, can target the inflammatory pathway. The purpose of this study was to investigate the effect of 4 weeks of aerobic training on the expression of IL-17 and IFN-γ in the hippocampus of rats with Alzheimer’s disease induced by amyloid-beta injection.
Methods: The 21 adult male Wistar rats were randomly divided into 3 groups of control (CG), Alzheimer’s, (AG) and Alzheimer’s+aerobic training (AAG). Beta-amyloid oligomers were used to induce Alzheimer’s disease in the hippocampus. A week after Alzheimer’s induction, rats of the AAG group performed exercise 5 days a week for 4 weeks. In the first and second weeks, the training session consisted of two 15 min sets with speed 10 m/m and a 5 min rest between sets. In the third and fourth weeks, the speed increased to 15 m/min and the number of sets to three and four 15 min, respectively (with 5 min rest between sets). After 4 weeks, hippocampal isolation from all rats and was used to evaluate cytokines gene expression.
Results: The results showed that IFN-γ gene expression was significantly lower in AAG group than AG group and significantly higher in the AAG and AG groups than CG group (p ≤ 0.05). Also, IL-17 gene expression was significantly lower in the AAG than AG group. While the IL-17 expression was significantly higher in the AG group than the CG group, there was no significant difference between the AAG and CG groups (p ≤ 0.05).
Conclusion: Aerobic training may help to alleviate the neuro-inflammation conditions that occur in Alzheimer’s disease by reducing the expression of pro-inflammatory cytokines such as IL-17 and IFN-γ.